INSYS THERAPEUTICS INC NEW's ticker is and the CUSIP is 45824V959. A total of 1 filers reported holding INSYS THERAPEUTICS INC NEW in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $42,000 | -46.2% | 9,100 | -59.2% | 0.00% | -100.0% |
| Q4 2018 | $78,000 | -87.0% | 22,300 | -62.5% | 0.00% | -80.0% |
| Q3 2018 | $599,000 | -33.5% | 59,400 | -52.3% | 0.01% | -37.5% |
| Q2 2018 | $901,000 | +381.8% | 124,500 | +301.6% | 0.01% | +300.0% |
| Q1 2018 | $187,000 | +74.8% | 31,000 | +179.3% | 0.00% | +100.0% |
| Q4 2017 | $107,000 | -10.8% | 11,100 | -17.8% | 0.00% | 0.0% |
| Q3 2017 | $120,000 | -51.4% | 13,500 | -30.8% | 0.00% | -66.7% |
| Q2 2017 | $247,000 | -65.5% | 19,500 | -71.4% | 0.00% | -62.5% |
| Q1 2017 | $716,000 | +795.0% | 68,100 | +682.8% | 0.01% | +700.0% |
| Q4 2016 | $80,000 | +73.9% | 8,700 | +123.1% | 0.00% | – |
| Q3 2016 | $46,000 | +31.4% | 3,900 | +44.4% | 0.00% | – |
| Q2 2016 | $35,000 | -96.2% | 2,700 | -95.4% | 0.00% | -100.0% |
| Q1 2016 | $929,000 | +295.3% | 58,100 | +608.5% | 0.01% | +333.3% |
| Q4 2015 | $235,000 | -66.6% | 8,200 | -66.8% | 0.00% | -70.0% |
| Q3 2015 | $703,000 | -77.1% | 24,700 | -71.1% | 0.01% | -76.7% |
| Q2 2015 | $3,071,000 | +25491.7% | 85,500 | +42650.0% | 0.04% | – |
| Q1 2015 | $12,000 | -7.7% | 200 | -33.3% | 0.00% | – |
| Q4 2014 | $13,000 | -90.2% | 300 | -91.2% | 0.00% | -100.0% |
| Q3 2014 | $132,000 | +594.7% | 3,400 | +466.7% | 0.00% | – |
| Q2 2014 | $19,000 | -83.6% | 600 | -80.0% | 0.00% | -100.0% |
| Q4 2013 | $116,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Thrax Management, LLC | 10,000 | $160,000 | 0.02% |
| GROUP ONE TRADING, L.P. | 58,100 | $929,000 | 0.01% |
| SIMPLEX TRADING, LLC | 427 | $63,000 | 0.01% |
| Citadel Advisors | 11,100 | $177,000 | 0.00% |